Startups
Vasopharm
https://vasopharm.comA company developing therapeutics for acute inflammatory central nervous system conditions
Summary
Total Funding
$24.3M
- Series F (2013-06-24) $6.5M
- Series D (2009-05-04) $6.0M
- Series B (2006-01-30) $11.8M
Investors
- Bayern Kapital Series F
- Bayern Kapital Series F
- Entrepreneurs Fund Series F
- Bayern Kapital Series B
- Bayern Kapital Series B
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable